Earnings Call Transcript - Q1FY21 for Aurobindo Pharma

Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Falling Comet

1120.2000 16.00 (1.45%)

NSE Jun 25, 2025 15:31 PM

29.64% Fall from 52W High

Volume: 816.9K

Conference/Earnings Calls Alerts

Aurobindo Pharma Ltd.

13 Aug 2020

1120.20

1.45%

Earnings Call Transcript - Q1FY21 for Aurobindo Pharma

Conference Call with Aurobindo Pharma Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.

More from Aurobindo Pharma Ltd.

Recommended

Market closes higher, Reliance Infra bags a Rs 600 cr export order for ammunition from Rheinmetall

Trendlyne Marketwatch | 25 Jun 2025, 03:56PM

Five stocks to buy from analysts this week - June 25, 2025

The Baseline | 25 Jun 2025, 11:20AM

A deal is called off, increasing the chance for Aurobindo Pharma to be debt free